The Measurement Instrument Adaptation (Structural Validity Test) of Mood and Anxiety Symptoms Questionnaire - Anhedonic Depression Scale in Indonesian Language

Abstract Background This study aimed at investigating: 1) the relationship between self-care agency and depression and anxiety; 2) the sociodemographic and clinical factors associated with depression and anxiety in patients with diabetic retinopathy (DR) in China. Methods A cross-sectional study was conducted. One-hundred and five patients with DR were recruited. Self-care agency was assessed by the exercise of self-care agency (ESCA) scale. Depression and anxiety were assessed by the hospital anxiety and depression scale (HADS-D and HADS-A). Pearson or Spearman correlations were performed to assess the association between self-care agency and depression and anxiety. Stepwise multivariate linear regression analyses were conducted to assess the contribution of the sociodemographic and clinical factors to depression and anxiety. Results Thirty-six (34.3%) and 43 (41.1%) patients exhibited depressive and anxiety symptoms, respectively. Only 24 (22.9%) patients showed a high self-care agency. The ESCA total and subscale scores were negatively correlated depressive symptoms (P < 0.05). Self-care skills were negatively correlated with anxiety symptoms (P < 0.05). ESCA total score, rural residence, history of hypertension and visual acuity were associated with depression; self-care skills and diastolic blood pressure were associated with anxiety. Conclusions Self-care agency negatively correlates with depression and anxiety in patients with DR. Special attention should be paid to patients living in rural areas and/or those having a history of hypertension when assessing depression and anxiety in patients with DR. Future studies are needed to clarify the causal relationship between self-care agency and depression and anxiety.

Download Full-text

Rates of Anxiety and Depressive Symptoms among Female Undergraduate Medical Students at National Medical College and Teaching Hospital

IRA-International Journal of Management & Social Sciences (ISSN 2455-2267) ◽

10.21013/jmss.v14.n2sp.p17 ◽

2019 ◽

pp. 171

Author(s):

Sandesh Sawant ◽

Garima Tripathi ◽

Tripti Pal Raman

Keyword(s):

Depressive Symptoms ◽

Medical Students ◽

Family History ◽

Depression Scale ◽

Anxiety Symptoms ◽

Drop Out ◽

Anxiety And Depression ◽

Female Undergraduate ◽

Undergraduate Medical Students ◽

The Mean

Background: Literature states that Depression and anxiety symptoms carry impairment to medical students, including poor academic performance, drop out, substance abuse and suicide. A high prevalence of anxiety and depression among medical students has been reported worldwide. Higher prevalence is noticed among female students.Aim/Objectives: To study rates of anxiety and depressive symptoms among female undergraduate medical students.Methods: The present study is a cross-sectional study. The purposive sampling method was used. Duration of study was 6 months. A total number of participants’ were 100. Self-developed questionnaire and Hospital Anxiety and Depression scale were used. Results: Findings showed that the mean score of anxiety symptoms was 8.08 (SD± 4.07). Similarly, the mean score of Depressive symptoms was 4.99(SD± 3.28). Fifty-two per cent of the students rated anxiety symptoms and 25% of the student rated depressive symptoms between borderline to the abnormal range. Total 9% of the students reported that they have a family history of mental illness among which 8% reported borderline to an abnormal range of anxiety however 52 % who had no family history also scored the same range. Similarly, 17% of the students reported there were life events which were stressful among which 13% scored borderline to abnormal range anxiety symptoms. Likewise, only 5% of the students scored borderline to the abnormal range of depressive symptoms.Conclusion: It was observed that female undergraduate medical students experience both anxiety and depressive symptoms however the percentage of depressive symptoms were less compared to anxiety symptoms. Further studies are required to evaluate the associated factors responsible for depressive and anxiety symptoms.

Download Full-text

Discrimination and structural validity evaluation of Zung self-rating depression scale for pregnant women in China

Journal of Psychosomatic Obstetrics & Gynecology ◽

10.1080/0167482x.2020.1770221 ◽

2020 ◽

pp. 1-9

Author(s):

Xinning Chen ◽

Weihong Hu ◽

Yao Hu ◽

Xian Xia ◽

Xiaotian Li

Keyword(s):

Pregnant Women ◽

Depression Scale ◽

Structural Validity ◽

Self Rating ◽

Validity Evaluation

Download Full-text

Fatigue in patients on oral targeted or chemotherapy for cancer and associations with anxiety, depression, and quality of life

Palliative & Supportive Care ◽

10.1017/s147895151900066x ◽

2019 ◽

Vol 18 (2) ◽

pp. 141-147

Author(s):

Hanneke Poort ◽

Jamie M. Jacobs ◽

William F. Pirl ◽

Jennifer S. Temel ◽

Joseph A. Greer

Keyword(s):

Quality Of Life ◽

Depressive Symptoms ◽

Oral Treatment ◽

Depression Scale ◽

Well Being ◽

Anxiety Symptoms ◽

Severe Fatigue ◽

Patient Reported ◽

The Impact

AbstractObjectivesOral treatment (targeted or chemotherapy) for cancer is being increasingly used. While fatigue is a known side effect of intravenous chemotherapy, the rate of fatigue and the impact of fatigue on other patient-reported outcomes are not well described.MethodAt Massachusetts General Hospital Cancer Center, 180 adult patients prescribed oral targeted or chemotherapy for various malignancies enrolled in a randomized controlled trial of adherence and symptom management. Patients completed baseline self-reported measures of fatigue (Brief Fatigue Inventory; BFI), anxiety and depressive symptoms (Hospital Anxiety and Depression Scale; HADS), and quality of life, including subscales for physical, social, emotional, and functional well-being ([QOL] Functional Assessment of Cancer Therapy — General; FACT-G). We examined clinically relevant fatigue using a validated cut-off score for moderate-severe fatigue (BFI global fatigue ≥4) and tested the associations with anxiety symptoms, depressive symptoms, and QOL with independent samples t-tests.ResultsAt baseline, 45 of 180 participants (25.0%) reported moderate-severe fatigue. Fatigued patients experienced more anxiety symptoms (mean diff. 3.73, P < 0.001), more depressive symptoms (mean diff. 4.14, P < 0.001), and worse QOL on the total FACT-G score (mean diff. −19.58, P < 0.001) and all subscales of the FACT-G compared to patients without moderate-severe fatigue.Significance of resultsOne in four patients on oral treatment for cancer experienced clinically relevant fatigue that is associated with greater anxiety and depressive symptoms and worse QOL.

Download Full-text

Social anxiety in a multiple sclerosis clinic population

Multiple Sclerosis Journal ◽

10.1177/1352458508099143 ◽

2009 ◽

Vol 15 (3) ◽

pp. 393-398 ◽

Cited By ~ 27

Author(s):

K Poder ◽

K Ghatavi ◽

JD Fisk ◽

TL Campbell ◽

S Kisely ◽

...

Keyword(s):

Social Anxiety ◽

Depression Scale ◽

Research Unit ◽

Anxiety Symptoms ◽

Self Report ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Neurological Disability ◽

General Anxiety ◽

Neurologic Disability

Background Little is known about social anxiety in MS. Objective We estimated the prevalence of social anxiety symptoms and their association with demographic and clinical features in a clinic-attending sample of patients with MS. Methods Patients attending the Dalhousie MS Research Unit for regularly scheduled visits completed the Social Phobia Inventory (SPIN), the Hospital Anxiety and Depression Scale (HADS), and the Health Utilities Index (HUI). Neurological disability was determined by ratings on the Expanded Disability Status Scale (EDSS). Results A total of 251 patients completed self-report scales of anxiety and depression symptoms. In all, 245 (98%) provided sufficient data for analysis. In all, 30.6% ( n = 75) had clinically significant social anxiety symptoms as defined by a SPIN threshold score of 19. Half of those with social anxiety had general anxiety (HADSA ≥ 11) and a quarter had depression (HADSD ≥ 11). Severity of social anxiety symptoms was associated with reduced health-related quality of life and not related to neurological disability. Conclusions Social anxiety symptoms are common in persons with MS, contribute to overall morbidity, but are unrelated to the overall severity of neurologic disability. Greater awareness and routine systematic inquiry of social anxiety symptoms is an important component of comprehensive care for persons with MS.

Download Full-text

Psychological distress in adults with congenital heart disease: focus beyond depression

Cardiology in the Young ◽

10.1017/s1047951118002068 ◽

2019 ◽

Vol 29 (2) ◽

pp. 185-189 ◽

Cited By ~ 9

Author(s):

Lacey P. Gleason ◽

Lisa X. Deng ◽

Abigail M. Khan ◽

David Drajpuch ◽

Stephanie Fuller ◽

...

Keyword(s):

Quality Of Life ◽

Congenital Heart Disease ◽

Heart Disease ◽

Congenital Heart ◽

Depression Scale ◽

Anxiety Symptoms ◽

Satisfaction With Life Scale ◽

Anxiety And Depression ◽

Depression Symptoms

AbstractBackgroundAdults with congenital heart disease face psychological challenges although an understanding of depression vs. anxiety symptoms is unclear. We analyzed the prevalence of elevated symptoms of anxiety and depression and explored associations with demographic and medical factors as well as quality of life.MethodsAdults with congenital heart disease enrolled from an outpatient clinic completed the Hospital Anxiety and Depression Scale and two measures of quality of life: the Linear Analogue Scale and the Satisfaction with Life Scale. Medical data were obtained by chart review.ResultsOf 130 patients (median age = 32 years; 55% female), 55 (42%) had elevated anxiety symptoms and 16 (12%) had elevated depression symptoms on subscales of the Hospital Anxiety and Depression Scale. Most patients with elevated depression symptoms also had elevated anxiety symptoms (15/16; 94%). Of 56 patients with at least one elevated subscale, 37 (66%) were not receiving mental health treatment. Compared to patients with 0 or 1 elevated subscales, patients with elevations in both (n=15) were less likely to be studying or working (47% vs. 81%; p=0.016) and reported lower scores on the Linear Analogue Scale (60 vs. 81, p<0.001) and the Satisfaction with Life Scale (14 vs. 28, p<0.001).ConclusionsAmong adults with congenital heart disease, elevated anxiety symptoms are common and typically accompany elevated depressive symptoms. The combination is associated with unemployment and lower quality of life. Improved strategies to provide psychosocial care and support appropriate engagement in employment are required.

Download Full-text

The Prevalence of Depression and Anxiety Symptoms among Overweight/Obese and Non-Overweight/Non-Obese Children/Adolescents in China: A Systematic Review and Meta-Analysis

International Journal of Environmental Research and Public Health ◽

10.3390/ijerph16030340 ◽

2019 ◽

Vol 16 (3) ◽

pp. 340 ◽

Cited By ~ 10

Author(s):

Simeng Wang ◽

Qi Sun ◽

Lingling Zhai ◽

Yinglong Bai ◽

Wei Wei ◽

...

Keyword(s):

Meta Analysis ◽

Depression Scale ◽

Middle School Student ◽

Chinese Economy ◽

Anxiety Symptoms ◽

Depression Symptoms ◽

Depression And Anxiety ◽

Obese Children ◽

Prevalence Of Depression ◽

Scale Types

With the dramatic growth of the Chinese economy, the number of children/adolescents with being overweight/having obesity is increasing, which has a certain impact on their psychology, such as depression and anxiety symptoms. Our purpose was to conduct a meta-analysis to assess the prevalence and odds ratios of depression and anxiety symptoms among overweight/obese children/adolescents and non-overweight/obese children/adolescents in China. As of July 2018, the three most comprehensive computerized academic databases in China have been systematically screened, namely China national knowledge infrastructure (CNKI) databases, Wanfang databases and Vip databases. The same operations are performed in PubMed and Web of Science (SCIE) databases without language restrictions. Case-control studies on prevalence of depression and anxiety symptoms in overweight/obese children/adolescents in China were analyzed. Study selection and evaluation were performed independently by three authors. Unweighted prevalence, pooled random-effects estimates of odds ratio (OR), and 95% confidence intervals (CI) were all calculated. A total of 11 eligible studies involving 17,894 subjects were included. The prevalence of depression and anxiety symptoms in overweight/obese children/adolescents was significantly higher than that in non-overweight/non-obese children/adolescents (depression: 21.73% vs. 17.96%, OR = 1.46, 95% CI: 1.14, 1.87, p = 0.003; anxiety: 39.80% vs. 13.99%, OR = 1.47, 95% CI: 1.21, 1.79, p < 0.001). Subgroup analyses conducted according to scale types showed that scale types have certain significance to evaluate the relationship between depression symptoms and overweight/obesity. The OR of depression symptoms between overweight/obese children/adolescents and non-overweight/non-obese children/adolescents was greatest on the Middle School Student Mental Health Scale (MSSMHS) was 2.06 (95% CI: 1.41, 3.02, I2 = 0.00%), Center for Epidemiologic Studies Depression Scale (CES-D) was 1.03 (95% CI: 0.84, 1.25, I2 = 0.00%), and Children’s Depression Inventory (CDI) was 1.21 (95% CI: 1.02, 1.42, I2 = 0.00%). We concluded that the prevalence of depression and anxiety symptoms in overweight/obese children/adolescents in China is higher than that in the non-overweight/obese children/adolescents. The results of the study indicate that the prevalence of depression and anxiety symptoms among overweight/obese children/adolescents in Chinese medical institutions should receive more attention. Physical exercise and psychological interventions should be strengthened to prevent psychological problems. However, because of some clear limitations (no clinical interview and few studies), these results should be interpreted with caution.

Download Full-text

Do patients with ICD who report anxiety symptoms on Hospital Anxiety and Depression Scale suffer from anxiety?

Journal of Psychosomatic Research ◽

10.1016/j.jpsychores.2019.03.183 ◽

2019 ◽

Vol 121 ◽

pp. 100-104 ◽

Cited By ~ 7

Author(s):

Selina Kikkenborg Berg ◽

Margrethe Herning ◽

Lau Caspar Thygesen ◽

Pernille Fevejle Cromhout ◽

Mette Kirstine Wagner ◽

...

Keyword(s):

Depression Scale ◽

Anxiety Symptoms ◽

Anxiety And Depression ◽

Hospital Anxiety

Download Full-text

Depressive Psoriasis-Patienten können ein schlechteres Ansprechen auf Etanercept zeigen

Karger Kompass Dermatologie ◽

10.1159/000496272 ◽

2019 ◽

Vol 7 (2) ◽

pp. 75-76

Author(s):

Wiebke Sondermann

Keyword(s):

Clinical Response ◽

Response Rate ◽

Depression Scale ◽

Female Gender ◽

Anxiety Symptoms ◽

Anxiety And Depression ◽

Depression Symptoms ◽

Etanercept Treatment ◽

Depressed Patients ◽

Pasi Score

Background/Aims: This study aimed to investigate the predicting values of depression and anxiety symptoms for clinical response to etanercept treatment in psoriasis patients. Methods: A total of 85 psoriasis patients who received 6 months of etanercept treatment were consecutively enrolled in this prospective cohort study. The Psoriasis Area and Severity Index (PASI) score was evaluated at month 0 (M0), M1, M3, and M6, and the corresponding PASI 75/90 response at each visit was assessed. Also, anxiety and depression symptoms were assessed by the Hospital Anxiety and Depression Scale (HADS) at M0, M1, M3, and M6. Results: Depression symptoms were observed to correlate with female gender (p = 0.004), longer disease duration (p = 0.018), and higher PASI score (p < 0.001), and anxiety symptoms were seen to be associated with female gender (p = 0.017), larger psoriasis-affected body surface area (p = 0.049), and higher PASI score (p = 0.017) in psoriasis patients. After etanercept treatment, HADS-Depression (HADS-D) and HADS-Anxiety (HADS-A) scores were both decreased at M1, M3, and M6 (all p < 0.001) compared with M0. Most importantly, baseline depressed patients presented with a lower PASI 75 response rate at M3 (p = 0.014) and M6 (p = 0.005), and a reduced PASI 90 response rate at M6 (p = 0.045) compared with baseline non-depressed patients. Furthermore, multivariate logistic regression analyses revealed that depression symptoms at baseline were an independent predictive factor for the lower possibility of both PASI 75 response (p = 0.048) and PASI 90 response (p = 0.048) achievements at M6 in psoriasis patients. However, no correlation of baseline anxiety symptoms with PASI 75/90 responses was observed. Conclusion: Depression symptoms at baseline independently predict a worse clinical response to etanercept treatment in psoriasis patients.

Download Full-text